Physician profile
Brandon K Hunter
NPI 1306917810
$67,845.40
in general payments reported to CMS, 2019-2025
24 companies · $988 in 2025
The $988 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62K · 2020: $789 · 2021: $928 · 2022: $1,669 · 2023: $1,013 · 2024: $890 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,868 · Entertainment: $22.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,867.91 |
| Entertainment | $22.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optovue, INC. | $60,000.00 | 2019 | |
| Coopervision INC. | $2,322.99 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Onefit Contact Lens |
| Allergan, INC. | $1,005.70 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $942.02 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $624.96 | 2020-2025 | Precision7, Precision 1, Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $487.10 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $454.08 | 2019-2025 | Cequa |
| Sight Sciences, INC. | $418.71 | 2021-2024 | Tearcare System |
| Johnson & Johnson Vision Care, INC. | $377.74 | 2019-2025 | Acuvue |
| Lkc Technologies, INC. | $200.33 | 2024-2025 | |
| Abb Con-Cise Optical Group LLC | $173.58 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Novartis Pharmaceuticals Corporation | $150.46 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $131.31 | 2024-2025 | Xdemvy |
| Abbvie INC. | $131.12 | 2022-2025 | |
| Genentech USA, INC. | $101.85 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $65.58 | 2020-2022 | |
| Maculogix, INC. | $65.18 | 2019-2020 | |
| Eyevance Pharmaceuticals LLC | $60.81 | 2022 | |
| Ani Pharmaceuticals, INC. | $35.44 | 2025 | Purified Cortrophin Gel |
| Biotissue Holdings INC. | $26.22 | 2019 | |
| Optos, INC. | $22.73 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $20.98 | 2019 | |
| Oyster Point Pharma, INC. | $14.70 | 2023 | Tyrvaya |
| Lombart Brothers, INC. | $11.81 | 2023 | Opd-III |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.